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Introduction: Schwannomas are mostly benign tumors arising from Schwann cells of the nerve sheaths. Breast
schwannomas are very rare and account for only 2.6% of cases. As far as we know this is the first reported case of
breast schwannoma discovered in a patient with diffuse large B-cell lymphoma. The breast schwannoma was
evaluated with positron emission tomography and it exhibited moderate 18F-fluorodeoxyglucose uptake.
Case presentation: We present the case of a breast schwannoma in a 63-year-old Caucasian woman who was
diagnosed with diffuse large B-cell lymphoma.
Conclusion: Imaging modalities including positron emission tomography-computed tomography failed to
distinguish breast schwannoma from diffuse large B-cell lymphoma involvement of the breast.
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SchwannomaIntroduction
Schwannoma is a slow-growing tumor arising from the
nerve sheath of peripheral, cranial and autonomic ner-
ves. It commonly occurs in the neck, head and exten-
sor surfaces of the extremities [1,2]. A schwannoma is
usually solitary and presents several years before diag-
nosis [3]. Breast-located schwannomas are unusual.
Das Gupta et al. reported the percentage of schwan-
nomas arising in the breast to be only 2.6% of all
schwannomas [4]. Diffuse large B-cell lymphoma
(DLBCL) constitutes approximately 30% of all lymph-
omas and is the most common subtype throughout
the world [5]. We report here a case of schwannoma
arising in the breast of a 63-year-old Caucasian woman
treated for DLBCL. To the best of our knowledge this is
the first reported case of schwannoma co-existing with
DLBCL and detected by positron emission tomography
(PET).
Case presentation
A 63-year-old Caucasian woman presented with a
three-month history of pelvic pain, urinary and fecal* Correspondence: aysesalihoglu@hotmail.com
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reproduction in any medium, provided the orincontinence and palpitations. Past medical and surgi-
cal histories were negative. On physical examination
the patient appeared ill. A rapid heart rate was pal-
pated which corresponded to atrial flutter on electro-
cardiography. Physical examination also revealed a left
breast mass, which the patient reported to be there for
25 years. It was a nontender, mobile, elastic hard and
well-circumscribed mass, two × one cm in size, with a
smooth surface located in the left lower inner quadrant.
Both axillae and supraclavicular fossae were negative on
palpation. No signs of nipple discharge and skin changes
were apparent. A thoracic computed tomography (CT)
scan revealed a mediastinal mass causing external com-
pression of the heart. The breast mass was identified on
thoracic CT as a hypodense lesion of one cm in diam-
eter. Magnetic resonance imaging (MRI) of the abdo-
men and pelvis exhibited multiple lymphadenopathies.
A diagnosis of non-Hodgkin’s lymphoma of diffuse large
B-cell type was established by Tru-CutW needle biopsy of
the pelvic lymphadenopathy. The patient’s general condi-
tion necessitated immediate initiation of chemotherapy
without further evaluation of the breast mass. A PET scan
scheduled to assess treatment response after two cycles of
rituximab, cyclophosphamide, doxorubicin, vincristine,
and prednisolone (R-CHOP) did not show any fluoro-
deoxyglucose (FDG) uptake in the lymph node areas.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Sagittal (a, b, c) and axial (d, e, f) positron emission tomography-computed tomography images demonstrating a small focal
region of moderate fluorodeoxyglucose uptake within the left breast (arrows) compared to normal parenchyma.
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Figure 2 The positron emission tomography-computed tomography images showing hypermetabolic mass lesion in the lower inner
quadrant of the left breast (selected arrows).
Salihoglu et al. Journal of Medical Case Reports 2012, 6:423 Page 3 of 6
http://www.jmedicalcasereports.com/content/6/1/423
Figure 3 Craniocaudal projection of the mammography
showing round circumscribed mass with sharply defined
margin in the inner part of the breast (arrow).
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initial CT image and on PET-CT images after two cycles
of R-CHOP did not reveal any difference in diameter. We
observed FDG accumulation in the breast mass with a
maximum standardized uptake value of three (Figures 1
and 2). Mammography revealed a circumscribed round-
shaped nodule (Figure 3), and the lesion was found to be a
well-demarcated hypoechoic mass by ultrasonography
(Figure 4). The differential diagnosis included fibro-
adenoma, breast cancer and lymphoma involving the
breast. The lesion was excised and the histopathologic
examination revealed that the tumor was composed of
spindle-shaped cells with nuclear palisading arranged in
interlacing bundles (Figure 5). There were no atypical
cells and mitotic figures. A final diagnosis of schwan-
noma was established by these consistent his-
topathological findings. The postoperative course was
uneventful and the patient was considered in completeFigure 4 Ultrasonographic image demonstrating a well-defined
hypoechoic ovoid mass with low amplitude internal echoes
and reflective shadowing at the edges.response according to PET-CT findings until presenting
with central nervous system involvement a month after
PET-CT. A regimen of cyclophosphamide, vincristine,
doxorubicin, dexamethasone, methotrexate and cytarabine
(hyper CVAD) was applied but our patient died at the end
of the first year after the diagnosis due to refractory dis-
ease. Schwannoma did not recur during the follow-up.Discussion
Schwannomas arise rarely within breast parenchyma
[6]. In the English language medical literature, 29 pre-
vious cases have been identified. According to Guido
Bellezza et al. most patients were female and the mean
age was 47 years. The tumors were most often located
in the upper outer quadrant, and tumor size ranged
from a few millimeters to 11cm [6]. Our patient pre-
sented with a solitary lesion measuring two × one cm
in diameter located in the lower inner quadrant. The
patient had first noticed the mass 25 years ago. Mani-
festations of genetic syndromes such as neurofibroma-
tosis types 1 and 2 or schwannomatosis were absent.
This benign tumor of the breast may simulate clinic-
ally a malignant neoplasm [7]. Taking the long history
and the same size of the breast mass in both the ini-
tial CT and the interim PET analysis into account, we
considered that the breast lesion was a benign one.
However, there was still a possibility of residual lym-
phoma involvement. It is difficult to diagnose intra-
mammary schwannoma on the basis of clinical and
radiologic findings [8]. Schwannoma was not diagnosed
prior to surgery in our patient and a final diagnosis
was established by histopathological examination of the
excised mass. The ultrasonographic and mammo-
graphic characteristics of the mass in our case were
similar to those described in the literature [6,8,9].
It is worth mentioning that we present here the first
case of schwannoma of the breast detected on PET,
thus far reported. There has been no documentation of
the PET findings of intramammary schwannomas. Vari-
ous schwannomas often have a high level of FDG up-
take [10,11]. Schwannomas originate from Schwann
cells, which produce the myelin sheath of the peripheral
nerves. Schwann cells transport glucose for axonal repo-
larization. This might be the cause of FDG uptake in
schwannomas, although the precise mechanism of FDG
accumulation in these benign tumors is not well
defined [12].
Schwannomas with high FDG uptake on PET have
been described in the brachial plexus [13], liver [14],
esophagus [12], posterior mediastinum [15], paraver-
tebral area [11], in the extremities [16], and chest
wall [17]. Chang et al. reported a case of a schwannoma
presenting as an enlarging cervical node demonstrated by
Figure 5 Spindle cells arranged in palisading fashion (hematoxylin and eosin × 40-100-100-200).
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lung cancer metastasis [18].
Conclusion
Here we presented a patient with DLBCL who coinci-
dentally happened to have a schwannoma in her
breast. PET is a cornerstone procedure in lymphoma
management. A PET-positive lesion does not necessar-
ily indicate a diagnosis of lymphoma. False positive
PET results are of paramount importance when de-
ciding on the patient’s management. False positives
occur in the setting of: inflammation, infection, and
necrosis; granulomatous disease including sarcoidosis,
thymic hyperplasia, and brown fat or with myeloid
growth factor; and rituximab use [19,20]. A diagnostic
work-up (a biopsy), just like we did with our patient,
should be performed in such patients with lymphoma
who have suspected lesions on PET-CT. Schwannoma
was a unforeseen diagnosis in the patient described
above. PET-positive lesions must be carefully inter-
preted and rare entities such as schwannomas should
be kept in mind in the differential diagnosis. Imaging
modalities including PET-CT failed to distinguish
breast schwannoma from DLBCL involvement of the
breast.
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